Quality spot checks of household blood collection needle products reveal that some items fail to meet standards.


Release date:

2025-09-15

Recently, market regulators conducted a special quality inspection on household blood collection needles currently available on the market, covering more than 20 brands and 50 batches of products.

Recently, market regulators conducted a special quality inspection of household blood collection needles currently available on the market. The inspection covered more than 20 brands and 50 batches of products, revealing that 6 batches failed to meet relevant standard requirements. Key issues included insufficient needle tip sharpness, inadequate sterility performance, and unclear scale markings.

Products with insufficient needle sharpness can increase user discomfort during blood collection, potentially even leading to failed attempts. Meanwhile, items that fail to meet sterility standards may cause infections at the blood-drawing site, posing significant health risks. And if the scale markings are unclear, users may struggle to accurately determine the correct blood-collection dosage. In response to substandard products identified during random inspections, market regulators have ordered affected companies to immediately halt sales and recall the problematic items, while also initiating formal investigations into these enterprises. Additionally, regulators urge consumers to purchase household blood collection needles only through authorized channels, carefully checking for essential details such as the product registration number, production date, and expiration date—avoiding "three-no" products altogether to ensure safety and quality.